Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT01504776 · COMPLETED
Trial details
- NCT number
- NCT01504776
- Sponsor
- Anand Jillella
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-09-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.